Immune Systems Advisor

Quick Answer A 2026 real-world survey of 506 verified purchasers of The Wellness Company's eight-medication Medical Emergency Kit found that 71.9% used the kit at least once, 81.6% reported meaningful improvement within three days of use, and 95.8% reported some form of net benefit. Only 2.4% reported side effects, all mild. The study is a preprint posted on Zenodo — not yet peer-reviewed — built entirely on self-reported data with no control group, and all 11 authors are affiliated with or compensated by the company selling the kit. It should be read as hypothesis-generating, not proof of clinical effectiveness. Key Takeaways The first real-world data on pre-prescribed emergency medication kits comes from a 506-respondent survey , posted as a Zenodo preprint on June 23, 2026 — it has not been peer-reviewed. 71.9% of purchasers used their kit at least once; 28.3% used it three or more times. Respiratory illness was the leading reason for use (59.4% of e...

In May 2026, a resurfaced video from the late Vladimir Zelenko (“Dr. Zev” Zelenko) went viral again on X, generating more than 1.5 million views and reigniting debate about zinc, vitamin D, and low-cost antiviral strategies. In the 2-minute clip (video below), Zelenko explains a concept he promoted heavily during the COVID-19 pandemic: many dangerous viruses share the same replication machinery, and therefore may share similar therapeutic vulnerabilities. The video specifically references: COVID-19 Influenza RSV Ebola virus disease Marburg virus disease Hantavirus infections His argument centers on zinc, zinc ionophores, and RNA-dependent RNA polymerase (RdRp), the enzyme many RNA viruses use to replicate. But does the science support the claim? Here’s a balanced, evidence-based review. What Is Hantavirus? Hantaviruses are rodent-borne RNA viruses that can cause severe human disease. Depending on the region and viral strain, infection may lead to: Hantavirus Pulmonary Syndrome (HPS) H...

As rates of infection with influenza and RSV rose in fall/winter 2022, FLCCC adapted the I-PREVENT protocol to include prevention against these viruses. The interventions recommended are likely to reduce the risk and severity of infection with COVID-19, influenza, and RSV infections as well as the common cold. It should be noted that the medications included in the I-PREVENT protocol are inexpensive, safe, and widely available. This protocol includes a section for pre-exposure (long-term) as well as a post-exposure (acute, short-term). ( Independent Medical Alliance ) About this Protocol The information in this document is FLCCC recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. New medications may be added and/or changes made to doses of existing medications a...

Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. Updates:  The Stratus Variant (XFG): Symptoms, Global Spread, and Impact in Late 2025 Note: According to Dr Pierre Kory, "...highlighting his objectivity, while Pierre Kory was once the leading advocate for ivermectin to treat COVID, he no longer does as the newer vari...